Prostate-Specific Antigen Density and Gleason Score Predict Adverse Pathologic Features in Patients with Clinically...

Area of Science:

• Urology
• Oncology
• Pathology

Background:

• Prostate cancer is a significant health concern, particularly among Iranian men.
• Radical prostatectomy is a standard treatment for localized prostate cancer.
• Predictive markers like Gleason score and PSA density are crucial for assessing disease severity.

Purpose of the Study:

• To assess the prognostic value of PSA density and Gleason score.
• To predict adverse pathological features in localized prostate cancer patients.
• To evaluate outcomes following radical prostatectomy.

Main Methods:

• Cross-sectional study of 105 patients undergoing radical prostatectomy (2006-2013).
• Collected data on Gleason scores, PSA levels, and post-operative pathological findings (EPE, SVI, LNI).
• Statistical analysis using SPSS version 21.

Main Results:

• Mean PSA density was 0.27.
• Frequencies of EPE, SVI, and LNI were 21.9%, 16.2%, and 2.9% respectively.
• PSA density showed a significant correlation with adverse pathological features (EPE, SVI, LNI).

Conclusions:

• PSA density and Gleason score are valuable predictors of adverse pathology.
• Integrated assessment of PSA, PSA density, and Gleason score enhances prediction accuracy.
• These markers aid in managing localized prostate cancer patients.